Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Naylor

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Oncology Research|January 1, 1994
Novel N-oxides as bioreductive drugsM A Naylor
Mini Reviews in Medicinal Chemistry|October 9, 2002
Recent advances in bioreductive drug targetingM A Naylor, P Thomson
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|January 7, 2003
Chaotic dynamics of an air-damped bouncing ballM A Naylor, P Sánchez, Michael R Swift
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|August 26, 2003
Air-driven Brazil nut effectM A Naylor, Michael R Swift, P J King
Anti-Cancer Drug Design|October 2, 1998
Targeting hypoxia with a new generation of indolequinonesM Jaffar, M A Naylor, N Robertson, et al.
Free Radical Research|August 1, 1996
Electron transfer reactions in RB90745, a bioreductive drug having both aromatic N-oxide and nitroarene moietiesK I Priyadarsini, M A Naylor, M R Stratford, et al.
Anti-Cancer Drug Design|October 2, 1998
Indolequinone bioreductive drugs: kinetic factors which influence selectivity for hypoxiaS A Everett, M A Naylor, J Nolan, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 1999
Bioreductively-activated prodrugs for targeting hypoxic tissues: elimination of aspirin from 2-nitroimidazole derivativesS A Everett, M A Naylor, K B Patel, et al.
Anti-Cancer Drug Design|January 1, 1997
S-2-amino-5-(2-nitroimidazol-1-yl)pentanoic acid: a model for potential bioreductively activated prodrugs for inhibitors of nitric oxide synthase (NOS) activityS Ulhaq, M A Naylor, E C Chinje, et al.
Radiation Research|June 1, 1994
Radiation-induced luminescence in DNA: evidence for long-range electron migrationA T al-Kazwini, G E Adams, P O'Neill, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Oncology Research|January 1, 1994
Novel N-oxides as bioreductive drugsM A Naylor
Mini Reviews in Medicinal Chemistry|October 9, 2002
Recent advances in bioreductive drug targetingM A Naylor, P Thomson
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|January 7, 2003
Chaotic dynamics of an air-damped bouncing ballM A Naylor, P Sánchez, Michael R Swift
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|August 26, 2003
Air-driven Brazil nut effectM A Naylor, Michael R Swift, P J King
Anti-Cancer Drug Design|October 2, 1998
Targeting hypoxia with a new generation of indolequinonesM Jaffar, M A Naylor, N Robertson, et al.
Free Radical Research|August 1, 1996
Electron transfer reactions in RB90745, a bioreductive drug having both aromatic N-oxide and nitroarene moietiesK I Priyadarsini, M A Naylor, M R Stratford, et al.
Anti-Cancer Drug Design|October 2, 1998
Indolequinone bioreductive drugs: kinetic factors which influence selectivity for hypoxiaS A Everett, M A Naylor, J Nolan, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 1999
Bioreductively-activated prodrugs for targeting hypoxic tissues: elimination of aspirin from 2-nitroimidazole derivativesS A Everett, M A Naylor, K B Patel, et al.
Anti-Cancer Drug Design|January 1, 1997
S-2-amino-5-(2-nitroimidazol-1-yl)pentanoic acid: a model for potential bioreductively activated prodrugs for inhibitors of nitric oxide synthase (NOS) activityS Ulhaq, M A Naylor, E C Chinje, et al.
Radiation Research|June 1, 1994
Radiation-induced luminescence in DNA: evidence for long-range electron migrationA T al-Kazwini, G E Adams, P O'Neill, et al.
Pageof 4